Clinical Trial Results: Positive data from clinical trials for Axsome's drug candidates typically drives the stock price up, while negative or inconclusive results can lead to a price decrease.

Regulatory Approval: FDA approval of Axsome's drugs is a major catalyst for stock price appreciation. Delays or rejection can negatively impact the stock.

Market Conditions: Overall market sentiment and economic conditions influence investor appetite for risk, impacting the valuations of biotechnology companies like Axsome.

Competition: The presence of competing drugs or therapies in Axsome's target markets affects the company's potential market share and profitability, influencing investor perceptions.

Financial Performance: Axsome's financial health, including cash reserves, revenue generation (if any), and spending rate, is scrutinized by investors and impacts stock price.

Partnerships and Collaborations: Strategic partnerships with other pharmaceutical companies can boost investor confidence and positively influence the stock price.

Intellectual Property: The strength and breadth of Axsome's patent portfolio protecting its drug candidates are important for long-term value and investor sentiment.

Management Team: Investor confidence in Axsome's leadership team and their ability to execute the company's strategy is a factor in stock valuation.

Analyst Ratings: Analyst recommendations and price targets can influence investor decisions and stock price movements.

News and Events: General news related to Axsome, the pharmaceutical industry, and healthcare policy can create short-term volatility in the stock price.